Total amount raised
$5 Millions
Latest funding date
11/1/2022
Location
Lindus Health has successfully raised $55 million in Series B funding to revolutionize the clinical trial landscape. The company offers a range of specialized CRO services, leveraging agile in-house technology and access to over 30 million electronic health records.
Keep reading to explore the intricacies of Lindus Health's fundraising journey and the investors backing this innovative platform.
What Is Lindus Health?
Lindus Health, founded in 2021, is a clinical research organization based in London, England. The company specializes in providing faster, more reliable clinical trials using innovative technology and a patient-centric approach.
Founded by Meriwether Beckwith, Michael Young, and Nik Haldimann, Lindus Health offers a range of services including trial design, patient recruitment, and trial delivery. Their in-house technology expedites site setup and patient recruitment, ensuring high standards of excellence.
With a team of 101-250 employees, Lindus Health is dedicated to transforming the clinical trial landscape, offering transparent pricing and fixed milestones to their clients.
How Much Funding Has Lindus Health Raised?
- Seed Round
- Amount Raised: $5M
- Date: November 2021
- Lead Investors: Firstminute Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish the company and develop initial technology for clinical trials.
- Angel Round
- Amount Raised: $1M
- Date: June 2023
- Lead Investors: Peter Thiel
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support early-stage operations and technology development.
- Grant
- Amount Raised: £436.6K
- Date: June 2023
- Lead Investors: Innovate UK
- Valuation at Round: Not applicable
- Motivation Behind the Round: To fund specific research projects and technological advancements.
- Series A
- Amount Raised: $18M
- Date: August 2023
- Lead Investors: Creandum
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the initial development and deployment of Lindus Health's platform and begin conducting clinical trials.
- Series B
- Amount Raised: $55M
- Date: January 2025
- Lead Investors: Balderton Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop AI technology and the eClinical platform, Citrus™, and to hire in key areas including clinical operations and product development.
Total Amount Raised: $79M
Current Valuation: Not publicly disclosed
Key Investors
- Balderton Capital
- Details: Balderton Capital is a multistage venture firm with over two decades of experience supporting European founders from Seed to IPO. They have both early and growth funds and invest across various technology sectors.
- Investment Focus Areas: AI, fintech, B2B SaaS, digital health, mobility, gaming, marketplace companies.
- Notable Investments: Darktrace, Depop, Flywire.
- Creandum
- Details: Creandum is a leading European early-stage venture capital firm. They focus on investing in innovative technology companies with high growth potential.
- Investment Focus Areas: Technology, fintech, health tech.
- Notable Investments: Spotify, Klarna, iZettle.
- Innovate UK
- Details: Innovate UK is the United Kingdom's innovation agency, driving productivity and economic growth by supporting businesses to develop and realize the potential of new ideas.
- Investment Focus Areas: Technology, healthcare, sustainability.
- Notable Investments: Not publicly disclosed.
- Peter Thiel
- Details: Peter Thiel is a renowned entrepreneur and venture capitalist, co-founder of PayPal and Palantir Technologies. He is known for his early investments in Facebook and other tech giants.
- Investment Focus Areas: Technology, biotech, fintech.
- Notable Investments: Facebook, Palantir Technologies, SpaceX.
- Firstminute Capital
- Details: Firstminute Capital is a seed-stage venture capital firm based in London. They focus on investing in technology startups at the earliest stages.
- Investment Focus Areas: Technology, AI, consumer tech.
- Notable Investments: CloudNC, Pangaia, Nothing.
What's Next for Lindus Health?
With the clinical trial industry valued at $112 billion, Lindus Health stands at the cusp of a transformative opportunity. Their AI-driven platform, Citrus™, promises to make clinical trials faster and more reliable, addressing inefficiencies that plague traditional CROs. The company has already conducted 42 trials and enrolled over 36,000 patients, showcasing their potential to scale operations and expand into new therapeutic areas and geographic regions.
Future fundraising efforts could see Lindus Health attracting more strategic investors to further develop their technology and expand their market reach. However, challenges such as regulatory compliance, data security, and competition from established CROs remain. Navigating these hurdles while maintaining the quality and reliability of their trials will be crucial for sustained growth.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Lindus Health and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
